| Financial Year |
March 31 2023 |
| Monetary Funds |
5,480,668,035.35 |
| Held-for-trading Financial Assets |
3,124,384,922.54 |
| Notes Receivable |
320,587,894.57 |
| Accounts Receivable |
2,934,800,057.53 |
| Advances to Suppliers |
802,861,232.05 |
| Other Receivables |
120,792,855.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,894,071,932.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
830,556,194.99 |
| Total Current Assets |
25,906,983,683.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
393,766,955.07 |
| Investment Properties |
-- |
| Fixed Assetes |
5,894,572,414.17 |
| Under-construction Projects |
2,947,915,909.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
670,988,767.31 |
| R&D expenses |
-- |
| Goodwill |
78,645,188.52 |
| Long-Term Deferred and Prepaid Expenses |
265,688,185.10 |
| Deferred Income Tax Assets |
310,406,929.40 |
| Other Non-Current Assets |
801,400,607.99 |
| Sub-Total of Non-Current Assets |
11,444,860,950.81 |
| Total Assets |
37,351,844,634.49 |
| Short-Term Loans |
2,644,390,465.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,743,030,409.18 |
| Accounts Payable |
4,349,416,183.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
494,341,680.60 |
| Taxes Payable |
336,697,016.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
708,744,424.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
770,887,665.73 |
| Other Current Liabilities |
128,139,935.07 |
| Sub-Total of Current Liabilities |
18,645,194,719.53 |
| Long-term Loans |
3,539,210,432.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
53,120,283.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,986,421,656.83 |
| Total Liabilities |
22,631,616,376.36 |
| Paid-In Capital(Or Share Stock) |
1,390,829,959.00 |
| Capital Surplus |
5,510,932,081.34 |
| Surplus Reserve |
261,111,426.60 |
| LESS:Treasury Stock |
84,547,761.80 |
| Undistributed Profits |
7,097,435,749.96 |
| Minority Stockholder's Interest |
543,552,370.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,176,675,887.16 |
| Owner's Equity（Stockholder's Equity） |
14,720,228,258.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,351,844,634.49 |
